Related Experiment Videos
Single additional dose postpartum therapy for women with chorioamnionitis
Rodney K Edwards1, Patrick Duff
1Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Florida College of Medicine, Gainesville, Florida 32610-0294, USA. edwardsr@obgyn.ufl.edu
Obstetrics and Gynecology
|December 16, 2003
Summary
A short course of antibiotics, specifically one additional postpartum dose, is adequate for treating chorioamnionitis in women. This approach effectively manages the infection without increasing treatment failures.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Pharmacology
Background:
- Chorioamnionitis is a common intrapartum infection.
- Prompt antibiotic treatment is crucial for maternal and fetal outcomes.
- Optimal duration of postpartum antibiotic therapy for chorioamnionitis requires further investigation.
Purpose of the Study:
- To evaluate the efficacy of a shortened postpartum antibiotic regimen for chorioamnionitis.
- To compare treatment failure rates between standard and short-course antibiotic groups.
Main Methods:
- A randomized controlled trial involving 292 women diagnosed with clinical chorioamnionitis.
- Intravenous ampicillin and gentamicin were administered intrapartum.
- Postpartum, women were randomized to either continue antibiotics (control) or receive a single additional dose (study group).
Main Results:
- No significant difference in treatment failure rates was observed between the control group (3.5%) and the study group (4.6%).
- The study met its recruitment target of 292 subjects.
Conclusions:
- A single additional postpartum dose of broad-spectrum antibiotics is sufficient for immune-competent women with chorioamnionitis treated promptly intrapartum.
- This finding supports a de-escalation of postpartum antibiotic duration in select cases.